Research Article

Vaspin Attenuates Atrial Abnormalities by Promoting ULK1/FUNDC1-Mediated Mitophagy

Figure 2

Vaspin supplementation attenuates Ang-II-induced atrial myocytes dysfunction. (a) MTT analysis revealed cell viability in Ang-II stimulated HL-1 cells treated with vaspin (1.0, 10, 100, and 1000 ng/mL), /group, data from three independent experiments. (b–c) Representative immunoblots and quantification of β-MHC, ANP, MMP-9, and MMP-2, /group, data from three independent experiments. (d) Representative images and quantification of phalloidin staining, . Data are presented as the , vs. control group, vs. Ang-II group.
(a)
(b)
(c)
(d)